Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment

BACKGROUND: Tyrosine kinase inhibitors (TKIs) remain the primary therapeutic option for patients with advanced-stage hepatocellular carcinoma (HCC). However, the selection of a suitable TKI is an issue in real-world clinical practice. Thus, this study aimed to identify patients most likely to benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Kun-Ming, Lai, Yin, Hung, Hao-Chien, Lee, Jin-Chiao, Cheng, Chih-Hsien, Wang, Yu-Chao, Wu, Tsung-Han, Lee, Chen-Fang, Wu, Ting-Jung, Chou, Hong-Shiue, Wang, Ching-Ting, Chai, Pei-Mei, Lien, Hsin-Yi, Lee, Wei-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946007/
https://www.ncbi.nlm.nih.gov/pubmed/36845025
http://dx.doi.org/10.2147/JHC.S393964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946007/
https://www.ncbi.nlm.nih.gov/pubmed/36845025
http://dx.doi.org/10.2147/JHC.S393964

Ejemplares similares